HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/5/955/650552/mdp532.pdf
Reference35 articles.
1. From the molecule to the clinic—inhibiting HER2 to treat breast cancer;Eisenhauer;N Engl J Med,2001
2. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors;Nielsen;Cancer Treat Rev,2009
3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
4. HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools;Hicks;Am J Clin Pathol,2008
5. From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy;Stacker;Lymphat Res Biol,2008
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lymphatic vessel: Origin, heterogeneity, biological functions and therapeutic targets;Signal Transduction and Targeted Therapy;2024-01-03
2. Predicting human epidermal growth factor receptor 2 status of patients with gastric cancer by computed tomography and clinical features;Gastroenterology Report;2023-12-22
3. Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients;Current Oncology;2023-02-27
4. Nanomedicines in Treatment of Cancer;Learning Materials in Biosciences;2023
5. Association of Relative Cerebral Blood Volume from Dynamic Susceptibility Contrast-Enhanced Perfusion MR with HER2 Status in Breast Cancer Brain Metastases;Academic Radiology;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3